HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$1.68
Day range
$1.64 - $1.70
Year range
$0.72 - $2.45
Market cap
89.70M USD
Avg Volume
366.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.90M | 11.91% |
Net income | -16.05M | 42.12% |
Net profit margin | — | — |
Earnings per share | -0.33 | — |
EBITDA | -9.86M | -12.07% |
Effective tax rate | -0.42% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.71M | -41.61% |
Total assets | 117.21M | -13.07% |
Total liabilities | 105.47M | 20.05% |
Total equity | 11.74M | — |
Shares outstanding | 53.71M | — |
Price to book | 7.64 | — |
Return on assets | -22.06% | — |
Return on capital | -77.84% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -16.05M | 42.12% |
Cash from operations | -11.42M | -30.62% |
Cash from investing | 6.04M | 221.31% |
Cash from financing | 14.41M | 41,077.14% |
Net change in cash | 9.06M | 165.04% |
Free cash flow | -6.85M | -31.97% |
About
Founded
2012
Headquarters
Website
Employees
36
